Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 1
2016 1
2017 2
2018 2
2019 3
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β.
Brownlie D, Doughty-Shenton D, Yh Soong D, Nixon C, O Carragher N, M Carlin L, Kitamura T. Brownlie D, et al. Among authors: doughty shenton d. J Immunother Cancer. 2021 Jan;9(1):e001740. doi: 10.1136/jitc-2020-001740. J Immunother Cancer. 2021. PMID: 33472858 Free PMC article.
A computationally designed binding mode flip leads to a novel class of potent tri-vector cyclophilin inhibitors.
De Simone A, Georgiou C, Ioannidis H, Gupta AA, Juárez-Jiménez J, Doughty-Shenton D, Blackburn EA, Wear MA, Richards JP, Barlow PN, Carragher N, Walkinshaw MD, Hulme AN, Michel J. De Simone A, et al. Among authors: doughty shenton d. Chem Sci. 2018 Oct 23;10(2):542-547. doi: 10.1039/c8sc03831g. eCollection 2019 Jan 14. Chem Sci. 2018. PMID: 30746096 Free PMC article.
Pharmacological targeting of the mitochondrial phosphatase PTPMT1.
Doughty-Shenton D, Joseph JD, Zhang J, Pagliarini DJ, Kim Y, Lu D, Dixon JE, Casey PJ. Doughty-Shenton D, et al. J Pharmacol Exp Ther. 2010 May;333(2):584-92. doi: 10.1124/jpet.109.163329. Epub 2010 Feb 18. J Pharmacol Exp Ther. 2010. PMID: 20167843 Free PMC article.